The week in health tech, explained in plain English.Get the free newsletter →
October 30, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Payers Bet on Analytics to Fix Maternal Care and Cut Costs

Health plans are leaning on data analytics to tackle one of the most expensive and stubborn problems in care: maternal health. The idea, as outlined by Healthcare Dive, is to use claims, clinical, and social data to flag high-risk pregnancies early and direct members to the right interventions before complications turn into costly emergencies.

In practice, that means surfacing risk factors like hypertension, diabetes, or missed prenatal visits, then closing gaps with outreach, care management, and timely referrals. The downstream targets are avoidable utilization that drives up spending, including emergency department visits, preterm births, and neonatal intensive care admissions. Postpartum follow-up, often a weak spot, is another focus area for analytics-driven monitoring.

The dual promise is improved outcomes for mothers and infants alongside a lower total cost of care. For payers facing scrutiny over maternal mortality and rising medical costs, analytics offers a way to intervene earlier rather than pay for preventable complications later.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.